Price FV - Search Results

1

Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).

Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Price FV, et al. Gynecol Oncol. 1993 Dec;51(3):383-9. doi: 10.1006/gyno.1993.1308. Gynecol Oncol. 1993. PMID: 8112650 Clinical Trial.

2

CA 125 may not reflect disease status in patients with uterine serous carcinoma.

Price FV, Chambers SK, Carcangiu ML, Kohorn EI, Schwartz PE, Chambers JT. Price FV, et al. Cancer. 1998 May 1;82(9):1720-5. doi: 10.1002/(sici)1097-0142(19980501)82:9<1720::aid-cncr19>3.0.co;2-6. Cancer. 1998. PMID: 9576294

3

Epithelioid angiosarcoma arising in uterine leiomyomas.

Tallini G, Price FV, Carcangiu ML. Tallini G, et al. Among authors: price fv. Am J Clin Pathol. 1993 Nov;100(5):514-8. doi: 10.1093/ajcp/100.5.514. Am J Clin Pathol. 1993. PMID: 8249890

4

Colony-stimulating factor-1 in primary ascites of ovarian cancer is a significant predictor of survival.

Price FV, Chambers SK, Chambers JT, Carcangiu ML, Schwartz PE, Kohorn EI, Stanley ER, Kacinski BM. Price FV, et al. Am J Obstet Gynecol. 1993 Feb;168(2):520-7. doi: 10.1016/0002-9378(93)90485-2. Am J Obstet Gynecol. 1993. PMID: 8438921

5

Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma.

Price FV, Amin RM, Sumkin J. Price FV, et al. Gynecol Oncol. 1999 Apr;73(1):140-4. doi: 10.1006/gyno.1998.5303. Gynecol Oncol. 1999. PMID: 10094895

6

Chemotherapy for malignant mixed Müllerian tumors of the ovary.

Sit AS, Price FV, Kelley JL, Comerci JT, Kunschner AJ, Kanbour-Shakir A, Edwards RP. Sit AS, et al. Among authors: price fv. Gynecol Oncol. 2000 Nov;79(2):196-200. doi: 10.1006/gyno.2000.5956. Gynecol Oncol. 2000. PMID: 11063643

7

A survey of blood transfusion practices of gynecologic oncologists.

Price FV, Kelley JL, Edwards RP, Hasley PB, Amin RM. Price FV, et al. Gynecol Oncol. 1995 Oct;59(1):45-50. doi: 10.1006/gyno.1995.1266. Gynecol Oncol. 1995. PMID: 7557614

8

Concurrent chemoradiation versus radiotherapy alone for the treatment of locally advanced cervical cancer in a low-resource setting.

Pereira E, Cooper HH, Zelaya PG, Creasman W, Price FV, Gupta V, Chuang L. Pereira E, et al. Among authors: price fv. Gynecol Oncol Rep. 2016 Dec 23;19:50-52. doi: 10.1016/j.gore.2016.12.006. eCollection 2017 Feb. Gynecol Oncol Rep. 2016. PMID: 28116341 Free PMC article.

9

A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer.

Vlad AM, Budiu RA, Lenzner DE, Wang Y, Thaller JA, Colonello K, Crowley-Nowick PA, Kelley JL, Price FV, Edwards RP. Vlad AM, et al. Among authors: price fv. Cancer Immunol Immunother. 2010 Feb;59(2):293-301. doi: 10.1007/s00262-009-0750-3. Cancer Immunol Immunother. 2010. PMID: 19690855 Free PMC article. Clinical Trial.

10

A trial of outpatient paclitaxel and carboplatin for advanced, recurrent, and histologic high-risk endometrial carcinoma: preliminary report.

Price FV, Edwards RP, Kelley JL, Kunschner AJ, Hart LA. Price FV, et al. Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-78-S15-82. Semin Oncol. 1997. PMID: 9346228 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters